Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ACC 2020: Medtronic’s Resolute Onyx DES Meets Goals In US/Japan High Bleeding Risk Patients

Apr 09 2020

• By Reed Miller

MDT Onyx Clear — Medtronic Resolute Onyx zotarolimus-eluting coronary stent • Source: Medtronic PLC

Related Content

TCT 2019: IDEAL LM Inconclusive, While Onyx ONE Boosts Polymer-Based DES

Sep 27 2019

Related Companies

Medtronic plc

Biosensors International Group Ltd.

Additional Topics

Clinical Trials Research & Development Cardiovascular Cardiology Medical Device

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.